ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer :

/PRNewswire/ -- On April 17, 2023, ImmVira announced the appointment of Dr. Oliver Kong as Chief Medical Officer (CMO). Dr. Kong will be fully in charge of...

Related Keywords

Qilu , Gansu , China , Shenzhen , Guangdong , , Us Medical Affairs At Bayer Healthcare Pharmaceuticals , University Of Nebraska Medical Center , Shanghai Medical College Of Fudan University , Qilu Pharmaceuticals , Oliver Kong , Chief Medical Officer , Shanghai Medical College , Fudan University , Molecular Immunology , Nebraska Medical , Corporate Vice President , Vice President , Clinical Oncology , Hengrui Therapeutics , Senior Global Medical Leader , Global Medical Affairs , Novartis Oncology , Senior Medical Director , Medical Director , Bayer Healthcare , Grace Zhou , Oncolytic Virus , Cancer Vaccine , Biosynthetic Exosome , Immvira ,